Drugs@FDA document
ONSOLIS Letter · NDA 022266 SUPPL-24
Drugs@FDA document · ADALVO · Dec 28, 2020
Key facts
| Drug name | ONSOLIS |
|---|---|
| Document type | Letter |
| Application | NDA022266 |
| Submission | SUPPL-24 |
| Company | ADALVO |
| Document date | Dec 28, 2020 |
| FDA document | accessdata.fda.gov |
At a glance
- REMS - MODIFIED - D-N-A Document categories
- 100–999 Documents for this application
- 1–9 USP chapters cited in this application's documents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA documents
Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date: